Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Dittrich

Showing results (91-100 of 229) with videos related to

Pageof 23
Sort By:
Journal of Cellular Physiology|April 1, 1992
The differential effects of N,N-dimethylformamide and transforming growth factor-beta 1 on a human ovarian cancer cell line (HOC-7)T W Grunt, C Somay, A Ellinger, et al.
British Journal of Cancer|September 1, 1993
Retinoic acid receptors in retinoid responsive ovarian cancer cell lines detected by polymerase chain reaction following reverse transcriptionH Harant, I Korschineck, G Krupitza, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Complete remission of metastasised clear cell sarcoma of tendons and aponeurosesG G Steger, F Wrba, R Mader, et al.
British Journal of Cancer|February 1, 1996
Genes related to growth and invasiveness are repressed by sodium butyrate in ovarian carcinoma cellsG Krupitza, S Grill, H Harant, et al.
British Journal of Cancer|July 1, 1995
Macrophage colony-stimulating factor is expressed by an ovarian carcinoma subline and stimulates the c-myc proto-oncogeneG Krupitza, R Fritsche, E Dittrich, et al.
Breast Cancer Research and Treatment|December 1, 1991
Phase II study of amonafide in advanced breast cancerW Scheithauer, C Dittrich, G Kornek, et al.
Geburtshilfe Und Frauenheilkunde|March 1, 1987
[Therapeutic and prognostic results of a prospective multicenter ovarian cancer study of FIGO stages I and II]P Sevelda, E Gitsch, C Dittrich, et al.
Stroke|June 1, 1989
Acute anticoagulation following cardioembolic strokeJ F Rothrock, H C Dittrich, S McAllen, et al.
International Journal of Oncology|October 17, 1998
Prediction of toxicity but not of clinical course by determining carboplatin exposure in patients with epithelial ovarian cancer treated with a combination of carboplatin and cisplatinA Obermair, P Speiser, M Thoma, et al.
Wiener Klinische Wochenschrift|April 27, 1984
[Mitoxantrone in the primary treatment of metastasizing breast cancer]R Lenzhofer, H Rainer, R Schuster, et al.
Pageof 23

Showing results (91-100 of 229) with videos related to

Sort By:
Pageof 23
Journal of Cellular Physiology|April 1, 1992
The differential effects of N,N-dimethylformamide and transforming growth factor-beta 1 on a human ovarian cancer cell line (HOC-7)T W Grunt, C Somay, A Ellinger, et al.
British Journal of Cancer|September 1, 1993
Retinoic acid receptors in retinoid responsive ovarian cancer cell lines detected by polymerase chain reaction following reverse transcriptionH Harant, I Korschineck, G Krupitza, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Complete remission of metastasised clear cell sarcoma of tendons and aponeurosesG G Steger, F Wrba, R Mader, et al.
British Journal of Cancer|February 1, 1996
Genes related to growth and invasiveness are repressed by sodium butyrate in ovarian carcinoma cellsG Krupitza, S Grill, H Harant, et al.
British Journal of Cancer|July 1, 1995
Macrophage colony-stimulating factor is expressed by an ovarian carcinoma subline and stimulates the c-myc proto-oncogeneG Krupitza, R Fritsche, E Dittrich, et al.
Breast Cancer Research and Treatment|December 1, 1991
Phase II study of amonafide in advanced breast cancerW Scheithauer, C Dittrich, G Kornek, et al.
Geburtshilfe Und Frauenheilkunde|March 1, 1987
[Therapeutic and prognostic results of a prospective multicenter ovarian cancer study of FIGO stages I and II]P Sevelda, E Gitsch, C Dittrich, et al.
Stroke|June 1, 1989
Acute anticoagulation following cardioembolic strokeJ F Rothrock, H C Dittrich, S McAllen, et al.
International Journal of Oncology|October 17, 1998
Prediction of toxicity but not of clinical course by determining carboplatin exposure in patients with epithelial ovarian cancer treated with a combination of carboplatin and cisplatinA Obermair, P Speiser, M Thoma, et al.
Wiener Klinische Wochenschrift|April 27, 1984
[Mitoxantrone in the primary treatment of metastasizing breast cancer]R Lenzhofer, H Rainer, R Schuster, et al.
Pageof 23